United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.
作者信息
Zic John A, Ai Weiyun, Akilov Oleg E, Carter Joi B, Duvic Madeleine, Foss Francine, Girardi Michael, Gru Alejandro A, Kim Ellen, Musiek Amy, Olsen Elise A, Schieke Stefan M, Shinohara Michi, Zain Jasmine M, Geskin Larisa J
机构信息
Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
出版信息
J Am Acad Dermatol. 2020 Aug;83(2):703-704. doi: 10.1016/j.jaad.2020.04.049. Epub 2020 Apr 16.
Abstract
摘要
相似文献
1
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.美国皮肤淋巴瘤协会关于在2019冠状病毒病大流行期间治疗皮肤淋巴瘤的建议。
J Am Acad Dermatol. 2020 Aug;83(2):703-704. doi: 10.1016/j.jaad.2020.04.049. Epub 2020 Apr 16.
2
A new nail in the CTCL coffin.皮肤T细胞淋巴瘤的又一不利因素。
J Invest Dermatol. 2006 Nov;126(11):2368-9. doi: 10.1038/sj.jid.5700558.
3
Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.COVID-19 大流行期间原发性皮肤淋巴瘤患者的管理：欧洲癌症研究与治疗组织皮肤淋巴瘤小组指南。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1633-1636. doi: 10.1111/jdv.16593. Epub 2020 Jul 7.
4
Immunobiology and treatment of cutaneous T-cell lymphoma.皮肤 T 细胞淋巴瘤的免疫生物学和治疗。
Expert Rev Clin Immunol. 2024 Aug;20(8):985-996. doi: 10.1080/1744666X.2024.2326035. Epub 2024 Mar 7.
5
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.原发性皮肤 T 细胞淋巴瘤（蕈样肉芽肿和赛泽里综合征）：第二部分。预后、治疗和未来方向。
J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033.
6
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.原发性皮肤 T 细胞淋巴瘤的发病机制和治疗：国际变态反应学会（CIA）2020 更新。
Int Arch Allergy Immunol. 2020;181(10):733-745. doi: 10.1159/000509281. Epub 2020 Jul 20.
7
Overview of Cutaneous T-Cell Lymphomas.皮肤 T 细胞淋巴瘤概述。
Hematol Oncol Clin North Am. 2019 Aug;33(4):669-686. doi: 10.1016/j.hoc.2019.04.004. Epub 2019 May 23.
8
Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.英国皮肤科医师协会与英国皮肤淋巴瘤小组关于原发性皮肤T细胞淋巴瘤管理的联合指南。
Br J Dermatol. 2003 Dec;149(6):1095-1107. doi: 10.1111/j.1365-2133.2003.05698.x.
9
[Cutaneous T-cell lymphoma].[皮肤T细胞淋巴瘤]
J Dtsch Dermatol Ges. 2003 Dec;1(12):965-80; quiz 981-2. doi: 10.1046/j.1439-0353.2003.03603.x.
10
Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).皮肤T细胞淋巴瘤（蕈样肉芽肿和塞扎里综合征）的全身治疗。
Ann Intern Med. 1994 Oct 15;121(8):592-602. doi: 10.7326/0003-4819-121-8-199410150-00007.
引用本文的文献
1
Consensus Guidelines for Teledermatology: Scoping Review.远程皮肤病学共识指南：范围综述
JMIR Dermatol. 2023 May 15;6:e46121. doi: 10.2196/46121.
2
Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings.氯苯丁胺凝胶治疗蕈样肉芽肿皮肤 T 细胞淋巴瘤患者：临床试验和真实世界环境中的疗效和安全性评价。
Adv Ther. 2022 Sep;39(9):3979-4002. doi: 10.1007/s12325-022-02219-w. Epub 2022 Jul 19.
3
Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID-19.一组皮肤T细胞淋巴瘤合并新型冠状病毒肺炎患者的临床结局
JAAD Int. 2022 Sep;8:52-55. doi: 10.1016/j.jdin.2022.04.008. Epub 2022 May 3.
4
Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco.原发性皮肤淋巴瘤与重症 COVID-19 风险：摩洛哥 48 例病例的前瞻性研究
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e512-e514. doi: 10.1111/jdv.18057. Epub 2022 Mar 17.
5
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.原发性皮肤淋巴瘤患者有患重症COVID-19的风险。来自西班牙原发性皮肤淋巴瘤登记处的数据。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e624-e626. doi: 10.1111/jdv.17430. Epub 2021 Jul 2.
6
Management of primary cutaneous lymphomas during the COVID-19 pandemic.COVID-19 大流行期间原发性皮肤淋巴瘤的治疗管理。
Clin Dermatol. 2021 Jan-Feb;39(1):64-75. doi: 10.1016/j.clindermatol.2020.12.014. Epub 2021 Jan 9.
7
Impact of COVID-19 pandemic on the management of cutaneous lymphomas.2019冠状病毒病大流行对皮肤淋巴瘤管理的影响。
Clin Dermatol. 2021 Jan-Feb;39(1):169-171. doi: 10.1016/j.clindermatol.2020.09.002. Epub 2020 Sep 7.
8
Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel).多中心研究淋巴瘤患者体内针对 COVID-19 的抗体血清阳性率：肿瘤治疗和淋巴瘤研究组（Gotel）的分析。
Curr Oncol. 2021 Mar 16;28(2):1249-1255. doi: 10.3390/curroncol28020118.
9
The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres.后疫情时代 COVID-19 对癌症护理的影响：亚洲主要癌症中心应对挑战和采取的对策中吸取的五大经验教训。
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):681-690. doi: 10.31557/APJCP.2021.22.3.681.
10
Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic.癌症还是新冠疫情？大流行之后安全癌症护理指南综述。
SN Compr Clin Med. 2020;2(12):2691-2701. doi: 10.1007/s42399-020-00632-2. Epub 2020 Nov 21.
本文引用的文献
1
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响：系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
2
Comorbidities and multi-organ injuries in the treatment of COVID-19.新型冠状病毒肺炎治疗中的合并症与多器官损伤
Lancet. 2020 Mar 21;395(10228):e52. doi: 10.1016/S0140-6736(20)30558-4. Epub 2020 Mar 11.
3
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
4
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
Zotero 插件